Harvard Bioscience Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 83.4 | 76.2 | 67.4 |
| Cost of Goods Sold | 43.2 | 38.1 | 34.2 |
| Gross Profit | 40.3 | 38.1 | 33.3 |
| Gross Profit Margin | 48.3% | 50.0% | 49.3% |
| SG&A Expense | 27.2 | 26.1 | 20.3 |
| Depreciation & Amortization | 3.5 | 3.3 | 5.0 |
| Operating Income | 9.5 | 8.7 | 7.9 |
| Operating Margin | 11.4% | 11.4% | 11.7% |
| Nonoperating Income | 0.4 | 0.1 | 0.1 |
| Nonoperating Expenses | 0.4 | 0.4 | 0.9 |
| Income Before Taxes | 9.6 | 8.4 | 7.1 |
| Income Taxes | 2.0 | 1.8 | 0.9 |
| Net Income After Taxes | 7.6 | 6.6 | 6.2 |
| Continuing Operations | 7.6 | 6.6 | 6.2 |
| Discontinued Operations | (8.9) | (9.0) | (38.1) |
| Total Operations | (1.4) | (2.3) | (31.9) |
| Total Net Income | (1.4) | (2.3) | (31.9) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.04) | (0.08) | (1.04) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
